Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Oakwood Labs specializes in the development and manufacturing of sustained-release injectable formulations using their proprietary Chroniject™ technology. With over 25 years of experience, they provide end-to-end solutions for pharmaceutical companies, ensuring quality and compliance throughout the drug development process.
Claim this profile to keep your information accurate and add what's missing.
Development and manufacturing of long-acting injectable formulations using the Chroniject™ technology platform.
Full-service contract development and manufacturing organization (CDMO) services for sustained release pharmaceuticals.
Chroniject™ is Oakwood Labs' proprietary polymer microsphere-based drug delivery technology that enables controlled release of active pharmaceutical ingredients over extended periods.
The Chroniject™ platform is compatible with small molecules, peptides, and proteins.
Long-acting injectables reduce injection frequency, improve patient compliance, target specific anatomical areas, and help prevent drug abuse.
Oakwood Labs is based in the Cleveland, Ohio area.
Oakwood Labs adheres to rigorous cGMP practices and maintains high standards of quality and regulatory compliance.